课题基金 / 基金详情

Elucidation of the radioresistance mechanism on the microenviroment of pancreatic cancer and control of the stroma cells causing radioresistance by newly artificial virus.

Elucidation of the radioresistance mechanism on the microenviroment of pancreatic cancer and control of the stroma cells causing radioresistance by newly artificial virus.
阐明胰腺癌微环境的放射抗性机制以及新型人工病毒对引起放射抗性的基质细胞的控制。
批准号:
24791431
负责人:
ONIMARU Manabu
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

ONIMARU Manabu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pancreatic ductal adenocarcinoma (PDA) is characterised by aggressive tumor spread, early metastasis and a poor prognosis. Standard therapy for PDA patients includes not only surgery and chemotherapy but also radiotherapy. However, there have been few detailed molecular biological studies to investigate about the effect of radiotherapy on PDA. It was reported that histone deacetylase 1 (HDAC1) is responsible for DNA repair of double strand breaks after irradiation in human fibroblasts. Here, we examined HDAC1 is involved in the mechanism of radioresistance of PDA. The irradiated pancreatic cancer cell lines reduced the radiosensitivity and increased the HDAC1 mRNA expression. The radioresistance was decreased after the addition of low-concentration TSA or knockdown of HDAC1 in pancreatic cancer cell lines. The present data suggested that HDAC1 is invoved in the mechanism of the radioresistance of pancreatic cancer cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jss.2012.06.051
发表时间: 2013-05-15
期刊: JOURNAL OF SURGICAL RESEARCH
影响因子: 2.2
作者: [Eguchi, Daiki, Ikenaga, Naoki, Tanaka, Masao]
通讯作者: Tanaka, Masao
膵癌細胞株におけるHiston deacetylase1の放射線耐性に関する評価
胰腺癌细胞系组蛋白脱乙酰酶1的放射抗性评价
DOI: --
发表时间:
期刊:
影响因子: --
作者: [田中友晴, 他]
通讯作者:
Histon Deacetylase 1 is Responsible for Radioresistance of Pancreatic Cancer cells
组蛋白脱乙酰酶 1 负责胰腺癌细胞的放射抗性
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Tanaka T, Ohuchida K, Mizumoto K, Kozono S, Tanaka M]
通讯作者: Tanaka M
Elucidation of the mechanism of anti-tumor effect by disabling the immune escape mechanism and development of treatment based on regulation of the pancreatic cancer microenvironment
  • 批准号:
    20K07678
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2020
  • 负责人:
    ONIMARU Manabu
  • 依托单位:
Clarification and control of immune cell-induced PSC substrate remodeling using KPCL mice
  • 批准号:
    17K10700
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2017
  • 负责人:
    ONIMARU Manabu
  • 依托单位:
Elucidation of selection mechanism of disseminated cancer cells in metastatic organs
  • 批准号:
    26462064
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.16万
  • 财政年份:
    2014
  • 负责人:
    ONIMARU Manabu
  • 依托单位:
Development of new functional artificial virus contained cancer-selective anticancer drug with the cancer-specific molecules
  • 批准号:
    22791255
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.58万
  • 财政年份:
    2010
  • 负责人:
    ONIMARU Manabu
  • 依托单位:
国内基金
海外基金
MIF/HDAC1 炎症-表观遗传轴介导三阴性炎性乳腺癌免疫抑制微环境的机制及干预研究
  • 批准号:
    2026JJ30207
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    黄隽
  • 依托单位:
乌司他丁靶向抑制HDAC1通过SOCS1/JAK2/STAT3 轴调控小胶质细胞极化来减轻局灶性脑缺血再灌注损伤的机制研究
  • 批准号:
    2026JJ81821
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    陈晓曦
  • 依托单位:
HDAC1协同IGFBP5促进肺癌干细胞自我更新的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    周优
  • 依托单位:
NAT9介导HDAC1乙酰化调控C-MYC促进结直肠癌发生发展及免疫逃逸的机制研究
  • 批准号:
    2025JJ60208
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    李乐
  • 依托单位: